CS
KITE

Credit Suisse’s Kite Pharma, Inc. KITE Stock Holding History

Credit Suisse’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-77,253
Closed -$13.9M – 4379
2017
Q3 		$13.9M Sell
77,253
-15,461
-17% -$2.15M 0.01% 1057
2017
Q2 		$9.61M Sell
92,714
-38,044
-29% -$3.1M 0.01% 1225
2017
Q1 		$10.3M Buy
130,758
+34,560
+36% +$2.14M 0.01% 1207
2016
Q4 		$4.31M Buy
96,198
+1,428
+2% +$70K ﹤0.01% 1762
2016
Q3 		$5.29M Buy
94,770
+26,197
+38% +$1.46M 0.01% 1616
2016
Q2 		$3.43M Buy
68,573
+16,887
+33% +$830K ﹤0.01% 1908
2016
Q1 		$2.37M Buy
51,686
+22,171
+75% +$1.07M ﹤0.01% 2072
2015
Q4 		$1.82M Buy
29,515
+11,927
+68% +$840K ﹤0.01% 2352
2015
Q3 		$979K Sell
17,588
-46,336
-72% -$2.91M ﹤0.01% 2842
2015
Q2 		$3.9M Buy
63,924
+17,687
+38% +$1.01M ﹤0.01% 1955
2015
Q1 		$2.67M Buy
46,237
+24,021
+108% +$1.61M ﹤0.01% 2154
2014
Q4 		$1.28M Buy
+22,216
New +$935K ﹤0.01% 2924

Credit Suisse's KITE Position: Q4 2017 in Review

Credit Suisse sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 77,253 shares — an estimated $13.9M sold.

Credit Suisse first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $13.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Credit Suisse reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Credit Suisse sold 77,253 Kite Pharma, Inc. shares in Q4 2017, an estimated $13.9M.
  • Credit Suisse first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • Credit Suisse's Kite Pharma, Inc. position peaked at $13.9M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.